{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:22:08Z","timestamp":1779898928836,"version":"3.53.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The optimal surgical treatment for patients presenting with (impending and complete) pathological proximal femoral fractures is predicated on prognosis. Guidelines recommend a preoperative biopsy to exclude sarcomas, however no evidence confirms a benefit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>This study aimed to describe the diagnostic accuracy, morbidity and sarcoma incidence of biopsy results in these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and Methods<\/jats:title>\n                <jats:p>All patients (<jats:italic>n<\/jats:italic>\u00a0=\u00a0153) presenting with pathological proximal femoral fractures between 2000 and 2019 were retrospectively evaluated. Patients after inadvertent surgery (<jats:italic>n<\/jats:italic>\u00a0=\u00a025) were excluded. Descriptive statistics were used to evaluate the accuracy and morbidity of diagnostic biopsies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 112\/128 patients who underwent biopsy, nine (8%) biopsies were unreliable either due to being inconclusive (<jats:italic>n<\/jats:italic>\u00a0=\u00a05) or because the diagnosis changed after resection (<jats:italic>n<\/jats:italic>\u00a0=\u00a04). Of impending fractures, 32% fractured following needle core biopsy. Median time from diagnosis to surgery was 30 days (interquartile range 21\u201346). The overall biopsy positive predictive value (PPV) to differentiate between sarcoma and non-sarcoma was 1.00 (95% confidence interval [CI] 0.88\u20131.00). In patients with a previous malignancy (<jats:italic>n<\/jats:italic>\u00a0=\u00a024), biopsy (<jats:italic>n<\/jats:italic>\u00a0=\u00a023) identified the diagnosis in 83% (PPV 0.91, 95% CI 0.71\u20130.99), of whom five (24%) patients had a new diagnosis. In patients without a history of cancer (<jats:italic>n<\/jats:italic>\u00a0=\u00a061), final diagnosis included carcinomas (<jats:italic>n<\/jats:italic>\u00a0=\u00a024, 39.3%), sarcomas (<jats:italic>n<\/jats:italic>\u00a0=\u00a024, 39.3%), or hematological malignancies (<jats:italic>n<\/jats:italic>\u00a0=\u00a013, 21.3%). Biopsy (<jats:italic>n<\/jats:italic>\u00a0=\u00a058) correctly identified the diagnosis in 66% of patients (PPV 0.80, 95% CI 0.67\u20130.90).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study confirms the importance of a preoperative biopsy in solitary pathological proximal femoral fractures due to the risk of sarcoma in patients with and without a history of cancer. However, biopsy delays the time to definite surgery, results can be inconclusive or false, and it risks completion of impending fractures.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-023-13931-4","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T13:01:59Z","timestamp":1690549319000},"page":"7882-7891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Importance of Awaiting Biopsy Results in Solitary Pathological Proximal Femoral Fractures"],"prefix":"10.1245","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8027-5888","authenticated-orcid":false,"given":"Floortje G. M.","family":"Verspoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9526-3775","authenticated-orcid":false,"given":"Gerjon","family":"Hannink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0845-9257","authenticated-orcid":false,"given":"Michael","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Jeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2869-6455","authenticated-orcid":false,"given":"Jonathan D.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"issue":"5","key":"13931_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3109\/0284186X.2010.484426","volume":"49","author":"HH Storm","year":"2010","unstructured":"Storm HH, Kejs AM, Engholm G, et al. Trends in the overall survival of cancer patients diagnosed 1964\u20132003 in the Nordic countries followed up to the end of 2006: the importance of case-mix. Acta Oncol. 2010;49(5):713\u201324.","journal-title":"Acta Oncol."},{"key":"13931_CR2","unstructured":"PH E. Cancer in the West Midlands. 2017."},{"issue":"7","key":"13931_CR3","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/bjc.2012.366","volume":"107","author":"J Maddams","year":"2012","unstructured":"Maddams J, Utley M, Moller H. Projections of cancer prevalence in the United Kingdom, 2010\u20132040. Br J Cancer. 2012;107(7):1195\u2013202.","journal-title":"Br J Cancer."},{"issue":"12","key":"13931_CR4","doi-asserted-by":"publisher","first-page":"e2248069","DOI":"10.1001\/jamanetworkopen.2022.48069","volume":"5","author":"C Palmieri","year":"2022","unstructured":"Palmieri C, Owide J, Fryer K. Estimated prevalence of metastatic breast cancer in England, 2016\u20132021. JAMA Netw Open. 2022;5(12):e2248069.","journal-title":"JAMA Netw Open."},{"issue":"1","key":"13931_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12893-018-0336-0","volume":"18","author":"G Guzik","year":"2018","unstructured":"Guzik G. Oncological and functional results after surgical treatment of bone metastases at the proximal femur. BMC Surg. 2018;18(1):5.","journal-title":"BMC Surg."},{"issue":"7","key":"13931_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.21037\/atm.2020.03.55","volume":"8","author":"JF Huang","year":"2020","unstructured":"Huang JF, Shen J, Li X, et al. Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study. Ann Transl Med. 2020;8(7):482.","journal-title":"Ann Transl Med."},{"issue":"2","key":"13931_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1302\/0301-620X.98B2.36185","volume":"98-B","author":"JD Stevenson","year":"2016","unstructured":"Stevenson JD, McNair M, Cribb GL, Cool WP. Prognostic factors for patients with skeletal metastases from carcinoma of the breast. Bone Joint J. 2016;98-B(2):266\u201370.","journal-title":"Bone Joint J."},{"issue":"3","key":"13931_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/CORR.0000000000001038","volume":"478","author":"NH Varady","year":"2020","unstructured":"Varady NH, Ameen BT, Chen AF. Is delayed time to surgery associated with increased short-term complications in patients with pathologic hip fractures? Clin Orthop Relat Res. 2020;478(3):607\u201315.","journal-title":"Clin Orthop Relat Res."},{"issue":"9","key":"13931_CR9","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1302\/0301-620X.99B9.BJJ-2017-0101.R1","volume":"99","author":"MC Fu","year":"2017","unstructured":"Fu MC, Boddapati V, Gausden EB, Samuel AM, Russell LA, Lane JM. Surgery for a fracture of the hip within 24 hours of admission is independently associated with reduced short-term post-operative complications. Bone Joint J. 2017;99(9):1216\u201322.","journal-title":"Bone Joint J."},{"issue":"3","key":"13931_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/BF03016088","volume":"55","author":"T Shiga","year":"2008","unstructured":"Shiga T, Wajima Z, Ohe Y. Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anaesth. 2008;55(3):146\u201354.","journal-title":"Can J Anaesth."},{"issue":"15","key":"13931_CR11","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1503\/cmaj.092220","volume":"182","author":"N Simunovic","year":"2010","unstructured":"Simunovic N, Devereaux PJ, Sprague S, et al. Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ. 2010;182(15):1609\u201316.","journal-title":"CMAJ."},{"issue":"3","key":"13931_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.arth.2018.11.006","volume":"34","author":"P Bovonratwet","year":"2019","unstructured":"Bovonratwet P, Fu MC, Adrados M, Ondeck NT, Su EP, Grauer JN. Unlike native hip fractures, delay to periprosthetic hip fracture stabilization does not significantly affect most short-term perioperative outcomes. J Arthroplasty. 2019;34(3):564\u20139.","journal-title":"J Arthroplasty."},{"issue":"6","key":"13931_CR13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.5858\/2008-132-931-MPOCRF","volume":"132","author":"G Disibio","year":"2008","unstructured":"Disibio G, French SW. Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med. 2008;132(6):931\u20139.","journal-title":"Arch Pathol Lab Med."},{"issue":"11","key":"13931_CR14","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1002\/cam4.1697","volume":"7","author":"M Riihimaki","year":"2018","unstructured":"Riihimaki M, Thomsen H, Sundquist K, Sundquist J, Hemminki K. Clinical landscape of cancer metastases. Cancer Med. 2018;7(11):5534\u201342.","journal-title":"Cancer Med."},{"issue":"Suppl 3","key":"13931_CR15","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.injury.2018.09.044","volume":"49","author":"A Angelini","year":"2018","unstructured":"Angelini A, Trovarelli G, Berizzi A, et al. Treatment of pathologic fractures of the proximal femur. Injury. 2018;49(Suppl 3):S77\u201383.","journal-title":"Injury."},{"issue":"3","key":"13931_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165\u201376.","journal-title":"Cancer Treat Rev."},{"key":"13931_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.blo.0000143572.96021.93","volume":"427","author":"DJ Jacofsky","year":"2004","unstructured":"Jacofsky DJ, Haidukewych GJ, Zhang H, Sim FH. Complications and results of arthroplasty for salvage of failed treatment of malignant pathologic fractures of the hip. Clin Orthop Relat Res. 2004;427:52\u20136.","journal-title":"Clin Orthop Relat Res."},{"issue":"1","key":"13931_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12885-017-3922-0","volume":"18","author":"RK Hernandez","year":"2018","unstructured":"Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer. 2018;18(1):44.","journal-title":"BMC Cancer."},{"issue":"4","key":"13931_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1634\/theoncologist.2015-0377","volume":"21","author":"R Tanaka","year":"2016","unstructured":"Tanaka R, Yonemori K, Hirakawa A, et al. Risk factors for developing skeletal-related events in breast cancer patients with bone metastases undergoing treatment with bone-modifying agents. Oncologist. 2016;21(4):508\u201313.","journal-title":"Oncologist."},{"issue":"4","key":"13931_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0030-5898(05)70171-1","volume":"31","author":"WD Hage","year":"2000","unstructured":"Hage WD, Aboulafia AJ, Aboulafia DM. Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin North Am. 2000;31(4):515\u201328.","journal-title":"Orthop Clin North Am."},{"issue":"8","key":"13931_CR21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jse.2011.06.019","volume":"21","author":"R Wedin","year":"2012","unstructured":"Wedin R, Hansen BH, Laitinen M, et al. Complications and survival after surgical treatment of 214 metastatic lesions of the humerus. J Shoulder Elbow Surg. 2012;21(8):1049\u201355.","journal-title":"J Shoulder Elbow Surg."},{"key":"13931_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/01.blo.0000170721.07088.2e","volume":"438","author":"M Talbot","year":"2005","unstructured":"Talbot M, Turcotte RE, Isler M, Normandin D, Iannuzzi D, Downer P. Function and health status in surgically treated bone metastases. Clin Orthop Relat Res. 2005;438:215\u201320.","journal-title":"Clin Orthop Relat Res."},{"issue":"8","key":"13931_CR23","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1097\/01.blo.0000534678.44152.ee","volume":"476","author":"MS Sorensen","year":"2018","unstructured":"Sorensen MS, Gerds TA, Hindso K, Petersen MM. External validation and optimization of the SPRING model for prediction of survival after surgical treatment of bone metastases of the extremities. Clin Orthop Relat Res. 2018;476(8):1591\u20139.","journal-title":"Clin Orthop Relat Res."},{"issue":"5","key":"13931_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/medicina46050045","volume":"46","author":"V Toliusis","year":"2010","unstructured":"Toliusis V, Kalesinskas RJ, Kiudelis M, Maleckas A, Griksas M. Surgical treatment of metastatic tumors of the femur. Medicina (Kaunas). 2010;46(5):323\u20138.","journal-title":"Medicina (Kaunas)."},{"key":"13931_CR25","doi-asserted-by":"publisher","first-page":"100213","DOI":"10.1016\/j.jbo.2018.100213","volume":"14","author":"L Zhang","year":"2019","unstructured":"Zhang L, Wang Y, Gu Y, Hou Y, Chen Z. The need for bone biopsies in the diagnosis of new bone lesions in patients with a known primary malignancy: a comparative review of 117 biopsy cases. J Bone Oncol. 2019;14:100213.","journal-title":"J Bone Oncol."},{"key":"13931_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/01.blo.0000229296.52216.77","volume":"451","author":"M Clayer","year":"2006","unstructured":"Clayer M, Duncan W. Importance of biopsy of new bone lesions in patients with previous carcinoma. Clin Orthop Relat Res. 2006;451:208\u201311.","journal-title":"Clin Orthop Relat Res."},{"issue":"2","key":"13931_CR27","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2214\/AJR.10.4934","volume":"196","author":"GA Toomayan","year":"2011","unstructured":"Toomayan GA, Major NM. Utility of CT-guided biopsy of suspicious skeletal lesions in patients with known primary malignancies. AJR Am J Roentgenol. 2011;196(2):416\u201323.","journal-title":"AJR Am J Roentgenol."},{"issue":"5","key":"13931_CR28","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.2214\/AJR.08.1882","volume":"193","author":"CG Cronin","year":"2009","unstructured":"Cronin CG, Cashell T, Mhuircheartaigh JN, et al. Bone biopsy of new suspicious bone lesions in patients with primary carcinoma: prevalence and probability of an alternative diagnosis. AJR Am J Roentgenol. 2009;193(5):W407-410.","journal-title":"AJR Am J Roentgenol."},{"issue":"6","key":"13931_CR29","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.2214\/AJR.12.10261","volume":"201","author":"B Raphael","year":"2013","unstructured":"Raphael B, Hwang S, Lefkowitz RA, Landa J, Sohn M, Panicek DM. Biopsy of suspicious bone lesions in patients with a single known malignancy: prevalence of a second malignancy. AJR Am J Roentgenol. 2013;201(6):1309\u201314.","journal-title":"AJR Am J Roentgenol."},{"issue":"1","key":"13931_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.18632\/oncotarget.2677","volume":"6","author":"J Budczies","year":"2015","unstructured":"Budczies J, von Winterfeld M, Klauschen F, et al. The landscape of metastatic progression patterns across major human cancers. Oncotarget. 2015;6(1):570\u201383.","journal-title":"Oncotarget."},{"issue":"7748","key":"13931_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1007-8","volume":"567","author":"OM Rueda","year":"2019","unstructured":"Rueda OM, Sammut SJ, Seoane JA, et al. Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups. Nature. 2019;567(7748):399\u2013404.","journal-title":"Nature."},{"issue":"5","key":"13931_CR32","doi-asserted-by":"publisher","first-page":"e1000279","DOI":"10.1371\/journal.pmed.1000279","volume":"7","author":"FM Blows","year":"2010","unstructured":"Blows FM, Driver KE, Schmidt MK, et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 2010;7(5):e1000279.","journal-title":"PLoS Med."},{"issue":"9972","key":"13931_CR33","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977\u20131010.","journal-title":"Lancet."},{"issue":"311","key":"13931_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/00016470410001708270","volume":"75","author":"BH Hansen","year":"2004","unstructured":"Hansen BH, Keller J, Laitinen M, et al. The scandinavian sarcoma group skeletal metastasis register. survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand Suppl. 2004;75(311):11\u20135.","journal-title":"Acta Orthop Scand Suppl."},{"issue":"3","key":"13931_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/01.NOR.0000320543.90115.d5","volume":"27","author":"SK Johnson","year":"2008","unstructured":"Johnson SK, Knobf MT. Surgical interventions for cancer patients with impending or actual pathologic fractures. Orthop Nurs. 2008;27(3):160\u201371.","journal-title":"Orthop Nurs."},{"issue":"2","key":"13931_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.suronc.2013.02.008","volume":"22","author":"M Ratasvuori","year":"2013","unstructured":"Ratasvuori M, Wedin R, Keller J, et al. Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis. Surg Oncol. 2013;22(2):132\u20138.","journal-title":"Surg Oncol."},{"key":"13931_CR37","doi-asserted-by":"publisher","first-page":"S230","DOI":"10.1097\/01.blo.0000093849.72468.82","volume":"415","author":"WG Ward","year":"2003","unstructured":"Ward WG, Holsenbeck S, Dorey FJ, Spang J, Howe D. Metastatic disease of the femur: surgical treatment. Clin Orthop Relat Res. 2003;415:S230-244.","journal-title":"Clin Orthop Relat Res."},{"issue":"7","key":"13931_CR38","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3390\/ph3072238","volume":"3","author":"O Guerin","year":"2010","unstructured":"Guerin O, Fischel JL, Ferrero JM, Bozec A, Milano G. EGFR targeting in hormone-refractory prostate cancer: current appraisal and prospects for treatment. Pharmaceuticals (Basel). 2010;3(7):2238\u201347.","journal-title":"Pharmaceuticals (Basel)."},{"issue":"4","key":"13931_CR39","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/CORR.0000000000001081","volume":"478","author":"AB Anderson","year":"2020","unstructured":"Anderson AB, Wedin R, Fabbri N, Boland P, Healey J, Forsberg JA. External validation of PATHFx version 3.0 in patients treated surgically and nonsurgically for symptomatic skeletal metastases. Clin Orthop Relat Res. 2020;478(4):808\u201318.","journal-title":"Clin Orthop Relat Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13931-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T19:08:50Z","timestamp":1696878530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13931-4"}},"subtitle":["Do We Need to Biopsy Solitary Pathological Fractures?"],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["13931"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13931-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Floortje G.M. Verspoor, Gerjon Hannink, Michael Parry, Lee Jeys, and Jonathan D. Stevenson have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This research was performed in accordance with the ethical standards of the Helsinki Declaration. The study protocol (registration number 22-066, November 2022) was retrospectively assessed by our Institutional Review Board (the Royal Orthopaedic Hospital, UK) and was carried out in accordance with the applicable rules concerning the review of research Ethics Committees and informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}